Meet the 2022 STAT Wunderkinds; Roche’s Alzheimer’s treatment fails to slow cognitive decline

Roche's investigational Alzheimer's disease treatment failed to meet the goals of two large studies. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   Meet the 2022 STAT Wunderkinds By STAT Staff Our search for the next generation of scientific superstars had a stellar sixth year. Introducing this year's class of STAT Wunderkinds. Read their stories. Read More STAT+: Roche's experimental Alzheimer's treatment fails to slow cognitive decline across two clinical trials By Adam Feuerstein and Damian Garde Sebastien Bozon/AFP via Getty Images The failure of the drug, called gantenerumab, is a setback for Roche and its efforts to develop a treatment for Alzheimer's Read More University of California academic workers go out on strike to demand higher wages By Jonathan Wosen Courtesy UAW Any other Monday morning, Josh Mesfin would have been in the lab, performing surgery on rats and devising new ways to help them heal from heart attacks — with the hope of one day using those same tools to help people. But the fourth-year UC San Diego bioengineering graduate student spent the day chanting and marching alongside fellow academic workers at 10 University of California campuses who launched a strike on Monday, decrying low wages that Mesfin says make instant ramen a dietary staple for many and that leave students struggling to afford the region’s rising rent. Read More Sponsored Insight by The University of Texas MD Anderson Cancer Center Research fueled by a shared mission to eliminate cancer STAT Wunderkinds have made discoveries that will have lasting impacts on health and medicine. Similarly, MD Anderson researchers are committed to advancing breakthroughs that will bring them closer to their goal to end cancer. These breakthroughs are made possible by MD Anderson's unique research enterprise, which fuels an ongoing cycle of innovation and translation. This brings insights from the lab to the clinic and back again, leading to practice-changing discoveries at unparalleled speed. The institution is seeking talented scientists to join its mission. Learn more here. Moderna data suggest new Covid booster is more effective against Omicron variants By Matthew Herper Jakub Porzycki/NurPhoto via AP Studies of the new bivalent boosters' effectiveness against new variants had been mixed. Moderna's new data point to added benefit. Read More Brains of Black Americans age faster, study finds, with racial stressors a likely factor By Usha Lee McFarling STAT The new study strengthens the case that vascular disease may be especially detrimental to brain health in Black populations. Read More STAT+: With VillageMD investment, Cigna bets on value-based care for a younger, healthier crowd By Tara Bannow Julia Rendleman/Getty Images for Eventive Marketing Insurers mastered profiting from value-based care under MA. With its $2.7 billion VillageMD acquisition, Cigna hopes to follow that route. Read More STAT+: Boom and bust: Whose biotech VC assets have grown and shrunk the most? By Allison DeAngelis and Kate Sheridan Adobe Data show that, while more established VC firms were able to capitalize on the biotech boom, Silicon Valley firms grew at far higher rates. Read More Opinion: Better access to amyloid-PET scans won't reduce racial inequities in Alzheimer's disease By Poul Høilund-Carlsen and Abass Alavi and Jorge R. Barrio FRED TANNEAU/AFP via Getty Images Opening access to PET-amyloid scans will result in more people misdiagnosed with Alzheimer's disease and given an unproven treatment for it. Read More STAT+: Google travels far from Silicon Valley to test the power of search tools in health care By Casey Ross Spencer Platt/Getty Images Google unveiled a pilot project to integrate its Care Studio search tool into Meditech EHRs at health systems in Wisconsin and Alabama. Read More STAT+: Maven raises $90 million for women's and family health amid a funding drought By Jayne Williamson-Lee Adobe Women’s and family health tech startup Maven Clinic announced Monday it has raised $90 million in a funding round led by General Catalyst. Read More Monday, November 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser